Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
Phase of Trial: Phase II
Latest Information Update: 24 Jul 2007
At a glance
- Drugs Tolvaptan (Primary)
- Indications Heart failure; Left ventricular dysfunction
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 24 Jul 2007 The expected completion date for this trial is now 1 Jul 2004.
- 05 Dec 2005 New trial record.